Cargando…
The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
The CRISPR‐Cas technologies derived from bacterial and archaeal adaptive immune systems have emerged as a series of groundbreaking nucleic acid‐guided gene editing tools, ultimately standing out among several engineered nucleases because of their high efficiency, sequence‐specific targeting, ease of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131926/ https://www.ncbi.nlm.nih.gov/pubmed/32037739 http://dx.doi.org/10.1111/jcmm.15039 |
_version_ | 1783517344963756032 |
---|---|
author | Wang, Jingyi Zhang, Chenzi Feng, Bo |
author_facet | Wang, Jingyi Zhang, Chenzi Feng, Bo |
author_sort | Wang, Jingyi |
collection | PubMed |
description | The CRISPR‐Cas technologies derived from bacterial and archaeal adaptive immune systems have emerged as a series of groundbreaking nucleic acid‐guided gene editing tools, ultimately standing out among several engineered nucleases because of their high efficiency, sequence‐specific targeting, ease of programming and versatility. Facilitated by the advancement across multiple disciplines such as bioinformatics, structural biology and high‐throughput sequencing, the discoveries and engineering of various innovative CRISPR‐Cas systems are rapidly expanding the CRISPR toolbox. This is revolutionizing not only genome editing but also various other types of nucleic acid‐guided manipulations such as transcriptional control and genomic imaging. Meanwhile, the adaptation of various CRISPR strategies in multiple settings has realized numerous previously non‐existing applications, ranging from the introduction of sophisticated approaches in basic research to impactful agricultural and therapeutic applications. Here, we summarize the recent advances of CRISPR technologies and strategies, as well as their impactful applications. |
format | Online Article Text |
id | pubmed-7131926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71319262020-04-06 The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations Wang, Jingyi Zhang, Chenzi Feng, Bo J Cell Mol Med Reviews The CRISPR‐Cas technologies derived from bacterial and archaeal adaptive immune systems have emerged as a series of groundbreaking nucleic acid‐guided gene editing tools, ultimately standing out among several engineered nucleases because of their high efficiency, sequence‐specific targeting, ease of programming and versatility. Facilitated by the advancement across multiple disciplines such as bioinformatics, structural biology and high‐throughput sequencing, the discoveries and engineering of various innovative CRISPR‐Cas systems are rapidly expanding the CRISPR toolbox. This is revolutionizing not only genome editing but also various other types of nucleic acid‐guided manipulations such as transcriptional control and genomic imaging. Meanwhile, the adaptation of various CRISPR strategies in multiple settings has realized numerous previously non‐existing applications, ranging from the introduction of sophisticated approaches in basic research to impactful agricultural and therapeutic applications. Here, we summarize the recent advances of CRISPR technologies and strategies, as well as their impactful applications. John Wiley and Sons Inc. 2020-02-10 2020-03 /pmc/articles/PMC7131926/ /pubmed/32037739 http://dx.doi.org/10.1111/jcmm.15039 Text en © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Reviews Wang, Jingyi Zhang, Chenzi Feng, Bo The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations |
title | The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations |
title_full | The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations |
title_fullStr | The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations |
title_full_unstemmed | The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations |
title_short | The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations |
title_sort | rapidly advancing class 2 crispr‐cas technologies: a customizable toolbox for molecular manipulations |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131926/ https://www.ncbi.nlm.nih.gov/pubmed/32037739 http://dx.doi.org/10.1111/jcmm.15039 |
work_keys_str_mv | AT wangjingyi therapidlyadvancingclass2crisprcastechnologiesacustomizabletoolboxformolecularmanipulations AT zhangchenzi therapidlyadvancingclass2crisprcastechnologiesacustomizabletoolboxformolecularmanipulations AT fengbo therapidlyadvancingclass2crisprcastechnologiesacustomizabletoolboxformolecularmanipulations AT wangjingyi rapidlyadvancingclass2crisprcastechnologiesacustomizabletoolboxformolecularmanipulations AT zhangchenzi rapidlyadvancingclass2crisprcastechnologiesacustomizabletoolboxformolecularmanipulations AT fengbo rapidlyadvancingclass2crisprcastechnologiesacustomizabletoolboxformolecularmanipulations |